14597-26-3Relevant articles and documents
BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00787-00789, (2019/06/05)
Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1 ), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.
Transformations of dialkyl(4-hydroxy-2-butynyl)-(3-phenylallyl)ammonium bromides in an KOH aqueous solution or in the presence of powdered KOH
Chukhadjian,Gabrielyan,Chukhadjian,Shahkhatuni,Panosyan
experimental part, p. 418 - 424 (2012/01/13)
Under the action of a twofold excess of KOH and heating in aqueous solution, and also under the conditions of the Stevens rearrangement (with KOH powder and a small amount of methanol) dialkyl-(4-hydroxy-2-butynyl)(3- phenylallyl)ammonium bromides form dialkyl[4-(1-phenylallyl)-2,5-dihydro-2- furyl]amines. Rearrangement-cleavage reaction also occurs under the same conditions.
Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives
Calogeropoulou, Theodora,Angelou, Panagiotis,Detsi, Anastasia,Fragiadaki, Irene,Scoulica, Effie
, p. 897 - 908 (2008/12/20)
Two series of novel ether phospholipids (EPs) have been synthesized. The first includes cyclodecylidene-or cyclopentadecylidene-substituted EPs carrying N,N,N-trimethylammonium or N-methylpiperidino or N-methylmorpholino head groups. The second series enc
